Skip to Main Content

Paper Details

Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
6
2023
Author NameAffiliation
Mitchell J FrederickBaylor College of Medicine
Jeffrey J KovacsThe University of Texas, MD Anderson Cancer Center
Timothy P HeffernanThe University of Texas, MD Anderson Cancer Center
William F SymmansThe University of Texas MD Anderson Cancer Center
Jeffrey N MyersThe University of Texas MD Anderson Cancer Center
  • 1 - 5

Datasets

Release 1.2